Inhibition of HBV-DNA replication and expression by siRNA based on magnetic nanoparticles transfering in HepG2 2.2.15 cells

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 6, 2010, Pages 543-548

  He, Yan ^a   Jiang, Yongfang ^a   Wang, Gufeng ^a   Luo, Hongyu ^a   Xiao, Xinqiang ^a   Deng, Chunming ^a   Luo, Kaizhong ^a   Su, Xianshi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

HBV; HBV core gene; Magnetic nanoparticles; SiRNA

Indexed keywords

HEPATITIS B CORE ANTIGEN; MAGNETITE NANOPARTICLE; RNA; SMALL INTERFERING RNA; VIRUS DNA;

ARTICLE; CELL STRAIN HEPG2; CHEMISTRY; DOWN REGULATION; GENETIC TRANSFECTION; GENETICS; HEPATITIS B VIRUS; HUMAN; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; VIRUS REPLICATION;

DNA, VIRAL; DOWN-REGULATION; HEP G2 CELLS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MAGNETITE NANOPARTICLES; RNA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; VIRUS REPLICATION;

EID: 77954795899     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.06.002     Document Type: Article

References (15)

1. Kao J H, Chen D S. Global control of hepatitis B virus infection [J]. Lancet Infect Dis, 2002, 2(7): 395-403.
2. Lee W M. Hepatitis B virus infection [J]. N Engl J Med, 1997, 337(24) :1733-1745.
3. Lok A S, McMahon B J. Chronic hepatitis B [J]. Hepatology, 2001, 34(6): 1225-1241.
4. Couzin J. Breakthrough of the year. Small RNAs make big splash [J]. Science, 2002, 298 (5602): 2296-2297.
5. Sijen T, Fleenor J, Simmer F, et al. On the role of RNA amplification in dsRNA-triggered gene silencing [J]. Cell, 2001, 107(4) :465-476.
6. Brummelkamp T R, Bernads R, Agami R. A system for stable expression of short interfering RNAs in Mammalian cells [J]. Science, 2002, 296(5567) :550-553.
7. Arbuthnot P, Thompson L J. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma [J]. World J Gastroenterol, 2008, 14 (11): 1670-1681.
8. Chen Y, Cheng G, Mahato R I. RNAi for treating hepatitis B viral infection [J]. Pharm Res, 2008, 25 (1): 72-86.
9. Li G Q, Gu H X, Li D, et al. Inhibition of hepatitis B virus cccDNA replication by siRNA [J]. Biochem Biophys Res Commun, 2007, 355(2) :404-408.
10. Giladi H, Ketzinel-Gilad M, Rivkin L, et al. Small interfering RNA inhibits hepatitis B virus replication in mice [J]. Mol Ther, 2003, 8(5): 769-776.
11. Kayhan H, Karatayli E, Turkyilmaz A R, et al. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2.2.215 cell lines [J]. Arch Virol, 2007, 152(5) :871-879.
12. WANG Wenlong, SUN Huiqing, YANG Xu, et al. Construction and identification of shRNA eukaryotic expression vectors specific to HBx gene integrated in human hepatocellular carcinoma cell line MHCC97-H[J]. Zhong Guo Yi Ke Da Xue Xue Bao, 2008, 37(4) :445-451.
13. He Y, He X E, Sun H Q, et al. Effect of HBx by RNAi association with chemotherapy in Hepatocellular carcinoma cell [J]. Zhong Nan Da Xue Xue Bao. Yi Xue Ban, 2009, 34(5) :395-1340
14. Ren J L, Pan J S, Cheng T, et al. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells [J]. Chin J Dig Dis, 2006, 7 (4) :230-236.
15. Wu K, Mu Y, Hu J, et al. Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system [J]. Antiviral Res, 2007, 74(2): 142-149.